NCT07613294: A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
- State
- Under way
- Phase
- Phase 3
- People
- 252 planned
- Started
- 1 Jun 2026
- Primary completion
- Dec 2029
- Arms
- Lepodisiran
- Results
- None posted
- 29 May 2026: Trial registered
- 1 Jun 2026: Trial started